SARA LEE: Open Payments
NPI 1871210278 · ENID, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 16 payments from 8 companies in 2025. Trend: 2023 $441 · 2024 $283 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $186 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $109 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: REXULTI, ZYNLONTA, FANAPT, ABILIFY MAINTENA, AUSTEDO XR, CAPLYTA, Cologuard Collection Kit, VRAYLAR.
Industry payments across OK — which companies pay providers there.
